{
    "Trade/Device Name(s)": [
        "Dimension Vista LOCI Digoxin Flex\u00ae reagent cartridge",
        "DIGXN (K6435)",
        "Dimension Vista Drug 4 Calibrator",
        "DRUG 4 CAL (KC460)"
    ],
    "Submitter Information": "Siemens Healthcare Diagnostics Inc.",
    "510(k) Number": "K093441",
    "Predicate Device Reference 510(k) Number(s)": [
        "K94615",
        "K011035"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "KXT",
        "JIX"
    ],
    "Summary Letter Date": "February 18, 2010",
    "Summary Letter Received Date": "February 22, 2010",
    "Submission Date": "October 30, 2009",
    "Regulation Number(s)": [
        "21 CFR 862.3320",
        "21 CFR 862.1150"
    ],
    "Regulation Name(s)": [
        "Digoxin test system",
        "Calibrator, multi-analyte mixture"
    ],
    "Analyte Class(es)": [
        "tdm",
        "toxicology",
        "chemistry"
    ],
    "Analyte(s)": [
        "Digoxin"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Dimension Vista System"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent immunoassay",
        "LOCI technology"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Reagent",
        "Calibrator",
        "Kit",
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for Dimension Vista LOCI Digoxin Flex reagent cartridge and Drug 4 Calibrator for quantitative measurement and calibration of digoxin in serum and plasma on Dimension Vista System",
    "Indications for Use Summary": "In vitro diagnostic test for quantitative measurement of digoxin in human serum and plasma to aid in diagnosis and treatment of digoxin overdose and in monitoring therapy; Drug 4 Calibrator for calibration of the LOCI Digoxin method on the Dimension Vista System",
    "fda_folder": "Toxicology"
}